{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:27:58Z","timestamp":1791066478697,"version":"4.1.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University","doi-asserted-by":"publisher","award":["D112-F2523"],"award-info":[{"award-number":["D112-F2523"]}],"id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University","doi-asserted-by":"publisher","award":["D114-F2515"],"award-info":[{"award-number":["D114-F2515"]}],"id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2321-B-006-023"],"award-info":[{"award-number":["NSTC 113-2321-B-006-023"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Evaluating the impact of antihypertensives on intradialytic hypotension (IDH) risk is crucial, given their frequent use in haemodialysis (HD) patients. This study assessed the comparative safety of various antihypertensives in relation to IDH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective cohort study at a tertiary medical centre in Taiwan included adult patients initiating HD from 2016 to 2021. Using electronic health records, we retrieved patient demographics and data covering the first 3\u00a0years of HD. We classified antihypertensives as angiotensin-converting enzyme inhibitors (ACEIs)\/angiotensin receptor blockers (ARBs), alpha blockers, beta blockers and dihydropyridine calcium channel blockers (DHP-CCBs). We defined IDH as a nadir intradialytic blood pressure decrease to &amp;lt;90\/100\u00a0mmHg (Nadir 90\/100) or a decrease of 40\u00a0mmHg (Fall 40). Using a generalized linear mixed model, we analysed odds ratios (ORs) and 95% confidence intervals (CIs) for IDH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>This study included 115 patients, covering 39\u00a0371 HD sessions over an average follow-up of 27.5\u00a0months. We identified 4534 IDH events based on Nadir 90\/100, with event rates of 5.0% for ACEIs\/ARBs, 3.0% for alpha blockers, 6.7% for beta blockers and 4.0% for DHP-CCBs. For Fall 40, we found 4814 IDH events, with rates of 11.5%, 7.7%, 11.4% and 9.2%, respectively. ACEIs\/ARBs and beta blockers did not significantly alter IDH risk. CCBs and alpha blockers significantly reduced IDH risk, with Nadir 90\/100\u2013adjusted ORs of 0.65 (95% CI 0.55\u20130.76) for CCBs and 0.57 (95% CI 0.43\u20130.74) for alpha blockers, compared with sessions without these medications. For Fall 40, adjusted ORs were 0.73 (95% CI 0.64\u20130.83) for CCBs and 0.61 (95% CI 0.49\u20130.74) for alpha blockers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Use of beta blockers and ACEIs\/ARBs had a neutral effect on IDH risk, while DHP-CCBs and alpha blockers were associated with lower risks of IDH and might be considered for patients with IDH risk factors. These findings support the safe use of antihypertensives in HD patients, offering valuable guidance for clinical medication adjustments.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf159","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T16:56:11Z","timestamp":1748019371000},"source":"Crossref","is-referenced-by-count":1,"title":["Risk of intradialytic hypotension among different antihypertensives in haemodialysis patients"],"prefix":"10.1093","volume":"18","author":[{"given":"Tzu-Ying","family":"Chen","sequence":"first","affiliation":[{"name":"School of pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University , Tainan ,","place":["Taiwan"]},{"name":"Tri-Service General Hospital Department of Pharmacy Practice, , Taipei ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7995-7408","authenticated-orcid":false,"given":"Miyuki Hsing-Chun","family":"Hsieh","sequence":"additional","affiliation":[{"name":"School of pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University , Tainan ,","place":["Taiwan"]},{"name":"Population Health Data Centre, National Cheng Kung University , Tainan ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Yi","family":"Su","sequence":"additional","affiliation":[{"name":"National Cheng Kung University Department of Computer Science and Information Engineering, , Tainan ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4986-0576","authenticated-orcid":false,"given":"Chung-Yi","family":"Li","sequence":"additional","affiliation":[{"name":"College of Medicine, National Cheng Kung University Department of Public Health, , Tainan ,","place":["Taiwan"]},{"name":"College of Public Health, China Medical University Department of Public Health, , Taichung ,","place":["Taiwan"]},{"name":"College of Medical and Health Science, Asia University Department of Healthcare Administration, , Taichung ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Cheng","family":"Wang","sequence":"additional","affiliation":[{"name":"National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Division of Nephrology, Department of Internal Medicine, , Tainan ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chung","family":"Tseng","sequence":"additional","affiliation":[{"name":"National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Division of Nephrology, Department of Internal Medicine, , Tainan ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5988-6123","authenticated-orcid":false,"given":"Kuan-Hung","family":"Liu","sequence":"additional","affiliation":[{"name":"National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Division of Nephrology, Department of Internal Medicine, , Tainan ,","place":["Taiwan"]},{"name":"Institute of Clinical Medicine, College of Medicine, National Cheng Kung University , Tainan ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hsien","family":"Chiang","sequence":"additional","affiliation":[{"name":"National Cheng Kung University Department of Computer Science and Information Engineering, , Tainan ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5852-7652","authenticated-orcid":false,"given":"Edward Chia-Cheng","family":"Lai","sequence":"additional","affiliation":[{"name":"School of pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University , Tainan ,","place":["Taiwan"]},{"name":"Population Health Data Centre, National Cheng Kung University , Tainan ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"2025061404515940800_bib1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.33549\/physiolres.934080","article-title":"Intradialytic hypotension: beyond hemodynamics","volume":"68","author":"Hajal","year":"2019","journal-title":"Physiol Res"},{"key":"2025061404515940800_bib2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1681\/ASN.2007091006","article-title":"Recent advances in the prevention and management of intradialytic hypotension","volume":"19","author":"Palmer","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"2025061404515940800_bib3","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/sdi.12633","article-title":"Impact of drugs on intradialytic hypotension: antihypertensives and vasoconstrictors","volume":"30","author":"Chang","year":"2017","journal-title":"Semin Dial"},{"key":"2025061404515940800_bib4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/ckj\/sfaa078","article-title":"An update review of intradialytic hypotension: concept, risk factors, clinical implications and management","volume":"13","author":"Kanbay","year":"2020","journal-title":"Clin Kidney J"},{"key":"2025061404515940800_bib5","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.2215\/CJN.02680314","article-title":"Intradialytic hypotension and risk of cardiovascular disease","volume":"9","author":"Stef\u00e1nsson","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025061404515940800_bib6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000486231","article-title":"Intradialytic hypotension as an independent risk factor for long-term mortality in maintaining hemodialysis patients: a 5-year follow-up cohort study","volume":"45","author":"Yu","year":"2018","journal-title":"Blood Purif"},{"key":"2025061404515940800_bib7","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/j.1523-1755.2004.00812.x","article-title":"Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients","volume":"66","author":"Shoji","year":"2004","journal-title":"Kidney Int"},{"key":"2025061404515940800_bib8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0002-9343(03)00366-8","article-title":"Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States","volume":"115","author":"Agarwal","year":"2003","journal-title":"Am J Med"},{"key":"2025061404515940800_bib9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/j.1542-4758.2011.00560.x","article-title":"Associations of endothelial dysfunction and arterial stiffness with intradialytic hypotension and hypertension","volume":"15","author":"Dubin","year":"2011","journal-title":"Hemodial Int"},{"key":"2025061404515940800_bib10","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.2215\/CJN.10010911","article-title":"Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction","volume":"7","author":"Inrig","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025061404515940800_bib11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/sdi.12631","article-title":"Special situations: intradialytic hypertension\/chronic hypertension and intradialytic hypotension","volume":"30","author":"Van Buren","year":"2017","journal-title":"Semin Dial"},{"key":"2025061404515940800_bib12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/sdi.12626","article-title":"Definitions of intradialytic hypotension","volume":"30","author":"Assimon","year":"2017","journal-title":"Semin Dial"},{"key":"2025061404515940800_bib13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.kint.2020.01.046","article-title":"Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"97","author":"Flythe","year":"2020","journal-title":"Kidney Int"},{"key":"2025061404515940800_bib14","doi-asserted-by":"publisher","first-page":"c137","DOI":"10.1159\/000092910","article-title":"Can predialysis hypertension prevent intradialytic hypotension in hemodialysis patients?","volume":"103","author":"Takeda","year":"2006","journal-title":"Nephron Clin Pract"},{"key":"2025061404515940800_bib15","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.34067\/KID.0001922021","article-title":"Timing of antihypertensive medications on key outcomes in hemodialysis: a cluster randomized trial","volume":"2","author":"Chang","year":"2021","journal-title":"Kidney360"},{"key":"2025061404515940800_bib16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00002480-199004000-00005","article-title":"Effect of predialysis verapamil on intradialytic blood pressure in chronic hemodialysis patients","volume":"36","author":"Sherman","year":"1990","journal-title":"ASAIO Trans"},{"key":"2025061404515940800_bib17","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1053\/j.ajkd.2015.10.029","article-title":"The \u03b2-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) feasibility study: a randomized controlled trial","volume":"67","author":"Roberts","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2025061404515940800_bib18","doi-asserted-by":"publisher","first-page":"e0126882","DOI":"10.1371\/journal.pone.0126882","article-title":"Short and long-term effects of the angiotensin ii receptor blocker irbesartan on intradialytic central hemodynamics: a randomized double-blind placebo-controlled one-year intervention trial (the SAFIR Study)","volume":"10","author":"Peters","year":"2015","journal-title":"PLoS One"},{"key":"2025061404515940800_bib19","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1093\/ndt\/gfn304","article-title":"Effect of amlodipine on cardiovascular events in hypertensive hemodialysis patients","volume":"23","author":"Tepel","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2025061404515940800_bib20","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1046\/j.1523-1755.1999.00359.x","article-title":"Supervised atenolol therapy in the management of hemodialysis hypertension","volume":"55","author":"Agarwal","year":"1999","journal-title":"Kidney Int"},{"key":"2025061404515940800_bib21","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1053\/ajkd.2001.29221","article-title":"Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses","volume":"38","author":"Agarwal","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"4 Suppl 3","key":"2025061404515940800_bib22","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients","volume":"45","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"2025061404515940800_bib23","doi-asserted-by":"publisher","first-page":"ii22","DOI":"10.1093\/ndt\/gfm019","article-title":"EBPG guideline on hemodynamic instability","volume":"22","author":"Kooman","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"2025061404515940800_bib24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1744-9987.2012.01088.x","article-title":"Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis","volume":"16","author":"Hirakata","year":"2012","journal-title":"Ther Apher Dial"},{"key":"2025061404515940800_bib25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12882-019-1527-3","article-title":"Renal Association clinical practice guideline on haemodialysis","volume":"20","author":"Ashby","year":"2019","journal-title":"BMC Nephrol"},{"key":"2025061404515940800_bib26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1681\/ASN.2014020222","article-title":"Association of mortality risk with various definitions of intradialytic hypotension","volume":"26","author":"Flythe","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"3 Suppl","key":"2025061404515940800_bib27","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","year":"2021","journal-title":"Kidney Int"},{"key":"2025061404515940800_bib28","article-title":"Hypertension in patients on dialysis","author":"Agarwal"},{"key":"2025061404515940800_bib29","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/s41440-021-00714-1","article-title":"Seasonal variation and predictors of intradialytic blood pressure decline: a retrospective cohort study","volume":"44","author":"Uchiyama","year":"2021","journal-title":"Hypertens Res"},{"key":"2025061404515940800_bib30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1152\/advan.00126.2014","article-title":"Recent advances in thermoregulation","volume":"39","author":"Tansey","year":"2015","journal-title":"Adv Physiol Educ"},{"key":"2025061404515940800_bib31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000245631","article-title":"Special considerations for antihypertensive agents in dialysis patients","volume":"29","author":"Redon","year":"2010","journal-title":"Blood Purif"},{"key":"2025061404515940800_bib32","doi-asserted-by":"publisher","first-page":"sfad304","DOI":"10.1093\/ckj\/sfad304","article-title":"Ambient temperature and the occurrence of intradialytic hypotension in patients receiving hemodialysis","volume":"17","author":"Liu","year":"2024","journal-title":"Clin Kidney J"},{"key":"2025061404515940800_bib33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2165\/00003495-198800355-00004","article-title":"Left ventricular hypertrophy and antihypertensive therapy","volume":"35","author":"Messerli","year":"1988","journal-title":"Drugs"},{"key":"2025061404515940800_bib34","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1111\/jch.14047","article-title":"Comparative efficacy of different types of antihypertensive drugs in reversing left ventricular hypertrophy as determined with echocardiography in hypertensive patients: a network meta-analysis of randomized controlled trials","volume":"22","author":"Chen","year":"2020","journal-title":"J Clin Hypertens"},{"key":"2025061404515940800_bib35","doi-asserted-by":"publisher","first-page":"C10","DOI":"10.1016\/0002-9149(94)90618-1","article-title":"Molecular basis of regression of cardiac hypertrophy","volume":"73","author":"Chevalier","year":"1994","journal-title":"Am J Cardiol"},{"key":"2025061404515940800_bib36","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/sdi.12369","article-title":"Antihypertensive medications in end-stage renal disease","volume":"28","author":"Denker","year":"2015","journal-title":"Semin Dial"},{"key":"2025061404515940800_bib37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/sdi.12498","article-title":"We hold antihypertensives prior to dialysis","volume":"29","author":"Krishnan","year":"2016","journal-title":"Semin Dial"},{"key":"2025061404515940800_bib38","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S0002-8703(96)90013-7","article-title":"Treatment and post-treatment effects of alpha- versus beta-receptor blockers on left ventricular structure and function in essential hypertension","volume":"132","author":"Schobel","year":"1996","journal-title":"Am Heart J"},{"key":"2025061404515940800_bib39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000063515","article-title":"Comparison of dialysis and clinical characteristics of patients with frequent and occasional hemodialysis-associated hypotension","volume":"25","author":"Tisl\u00e9r","year":"2002","journal-title":"Kidney Blood Press Res"},{"key":"2025061404515940800_bib40","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1001\/jama.1996.03530430051039","article-title":"Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies","volume":"275","author":"Schmieder","year":"1996","journal-title":"JAMA"},{"key":"2025061404515940800_bib41","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/0002-9149(92)91192-7","article-title":"Relation of regression of left ventricular hypertrophy to changes in ambulatory blood pressure after long-term therapy with perindopril versus nifedipine","volume":"70","author":"Schulte","year":"1992","journal-title":"Am J Cardiol"},{"key":"2025061404515940800_bib42","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1038\/sj.ki.5001983","article-title":"Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis","volume":"70","author":"Aslam","year":"2006","journal-title":"Kidney Int"},{"key":"2025061404515940800_bib43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1161\/01.CIR.82.1.105","article-title":"Salt and water retention and calcium blockade in uremia","volume":"82","author":"London","year":"1990","journal-title":"Circulation"},{"key":"2025061404515940800_bib44","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1172\/JCI111023","article-title":"Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha 1 adrenergic response","volume":"72","author":"Simpson","year":"1983","journal-title":"J Clin Invest"},{"key":"2025061404515940800_bib45","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/00005344-199910000-00016","article-title":"Effects of doxazosin and atenolol on circulating endothelin-1 and von Willebrand factor in hypertensive middle-aged men","volume":"34","author":"Seljeflot","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"2025061404515940800_bib46","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0026-0495(03)00190-2","article-title":"Effect of the alpha-adrenergic blocker, doxazosin, on endothelial function and insulin action","volume":"52","author":"Courtney","year":"2003","journal-title":"Metabolism"},{"key":"2025061404515940800_bib47","doi-asserted-by":"publisher","first-page":"139S","DOI":"10.1016\/0895-7061(96)00289-0","article-title":"Overview of alpha 1-adrenoceptor antagonism and recent advances in hypertensive therapy","volume":"9","author":"Veelken","year":"1996","journal-title":"Am J Hypertens"},{"key":"2025061404515940800_bib48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/sdi.12777","article-title":"Timing of blood pressure medications and intradialytic hypotension","volume":"32","author":"Wang","year":"2019","journal-title":"Semin Dial"},{"key":"2025061404515940800_bib49","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000531477","article-title":"Association of intradialytic hypertension with future cardiovascular events and mortality in hemodialysis patients: effects of ambulatory blood pressure","volume":"54","author":"Iatridi","year":"2023","journal-title":"Am J Nephrol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf159\/63310573\/sfaf159.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/6\/sfaf159\/63310573\/sfaf159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/6\/sfaf159\/63310573\/sfaf159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T08:52:02Z","timestamp":1749891122000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf159\/8142534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf159","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,5,23]]},"article-number":"sfaf159"}}